Some people naturally eat less on GLP-1 medications, but skipping too many meals may make it harder to get enough protein, fluids, fiber, and nutrients
Tirzepatide best result: 22.5% body weight loss over 72 weeks on the 15mg dose, versus 2.4% for placebo
You can read the full article at Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats The drug tesofensine, which blocks the reuptake of dopamine, serotonin, and norepinephrine, has shown promise as a treatment for obesity
Common Side Effects of Retatrutide Retatrutide has shown promising results in clinical research for weight loss, but like all medications, it can cause side effects
Estrogen influences leptin sensitivity and ghrelin secretion differently than testosterone, potentially creating a more favorable response to GLP-1 receptor agonism